Occudo Quantitative Strategies’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-39,060
Closed -$937K 821
2023
Q4
$937K Buy
+39,060
New +$849K 0.13% 221
2022
Q3
Sell
-23,768
Closed -$495K 1258
2022
Q2
$495K Buy
+23,768
New +$490K 0.04% 623

Other funds holding EXEL

Occudo Quantitative Strategies's EXEL Position: Q1 2024 in Review

Occudo Quantitative Strategies sold out of Exelixis (EXEL) in Q1 2024, closing a stake of 39,060 shares — an estimated $937K sold.

Occudo Quantitative Strategies first reported a position in EXEL in Q2 2022 and held it in 2 quarters. The position peaked at $937K in Q4 2023. 422 funds tracked by Wall St. Rank hold EXEL as of Q1 2024.

  • Occudo Quantitative Strategies reported no remaining Exelixis position as of Q1 2024 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 39,060 Exelixis shares in Q1 2024, an estimated $937K.
  • Occudo Quantitative Strategies first reported a position in Exelixis in Q2 2022 and held it in 2 quarters.
  • Occudo Quantitative Strategies's Exelixis position peaked at $937K in Q4 2023.
  • 422 funds tracked by Wall St. Rank held Exelixis as of Q1 2024.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2024, filed 15 May 2024.